Home|News

La Bourse et la vie: Lloyd Diamond Managing Director Pixium Vision: “Start the pivotal study”. Web TV meets leaders at Biomed Event 2020

Pixium Vision recently announced the success of the first implantation of the Prima System in an American patient with dry age-related Macular Degeneration (AMD). The intervention was carried out, within the framework of the American feasibility study, in the Department of Ophthalmology of the medical center of the University of Pittsburgh (UPMC).

Pixium Vision is developing innovative visual restoration systems (SRV) that stimulate the retina to achieve bionic vision.

Interview by journalist Didier Testot on the Web Tv www.labourseetlavie.com

Watch video
2020-02-04T13:15:34+01:00February 4th, 2020|News|

(FR) Demain, pourra-t-on soigner la DMLA grâce à une rétine artificielle ?

Almost 200 million people over the age of 50 are visually impaired worldwide and there is no cure. However, tomorrow, blindness will no longer be inevitable thanks to an artificial retina system.

Watch video
2020-01-31T11:00:21+01:00January 31st, 2020|News|

(FR) BFM Life : Innovations for your vision

This Sunday, January 26, Serge Picaud, Inserm research director at the Vision Institute, Christine Placet, CEO of Hororama, Raphaël Amar, director of the “Visual Health” department of ZEISS Vision Care, and Lloyd Diamond, CEO from Pixium Vision, returned to innovations in the field of vision, whether from manufacturers of optical equipment, or scientific advances in the field of ophthalmogolia, in the program BFM Life presented by Julien Gagliardi and Lorraine Goumot.

Watch video
2020-01-27T09:54:38+01:00January 26th, 2020|News|

Pixium Vision developing an implant and bionic vision system to improve patient’s sight

Pixium Vision (EURONEXT:PIX) CEO Lloyd Diamond sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Paris-based bioelectronics company is developing innovative bionic vision systems to enable patients who have lost their sight to lead more independent lives.

Watch video
2020-01-21T12:17:51+01:00January 21st, 2020|News|

Prof. Daniel Palanker and Dr. Yannick Le Mer received the Bartimaeus award

Congratulations to Professor Daniel Palanker of the Stanford University Department of Ophthalmology, School of Medicine, and Hansen Experimental Physics Laboratory and Dr. Yannick Le Mer of the Fondation Adophe de Rothschild for winning the prestigious Bartimaeus award, due to their scientific and clinical research on the PRIMA Bionic Vision System, at this year’s Eye and The Chip World Research Conference at the Detroit Institute of Ophthalmology and the Henry Ford Department of Ophthalmology. “The Bartimaeus Award is presented to an investigator who has distinguished him or herself, by prolonged substantial contributions to the progress in the field of Artificial Vision.”

 

2019-11-14T11:31:21+01:00November 14th, 2019|News|

New technologies promise sharper artificial vision for blind people

The Paris-based company Pixium Vision is testing the device in five people who have the photoreceptor-destroying disease macular degeneration. At last week’s meeting, Palanker presented videos showing that participants who had been implanted with the prosthesis for about 1 year could recognize objects on a table and read printed or on-screen letters. The artificial vision is good enough to make out the title of a book, Palanker says, though not the words on its pages. His team is now working to shrink the photodiodes—creating finer pixels and sharper vision—without losing too much signal strength.

Read more  »

2019-11-05T14:33:29+01:00November 5th, 2019|News|

Pixium Vision: “For biotechs, Euronext becomes a Third World market”

(BFM Bourse) – The decline of biotech intensifies, Pixium now drop more than 30% over the last five sessions and 40% over a month, with no particular relevance. A movement whose financial director admits he does not understand the outcome, which leads him to question the future of the sector but also future of Euronext.

Read more (French) »

2019-10-09T11:18:49+02:00October 9th, 2019|News|

How Pixium Vision’s bionic vision systems can be a new hope for the blind


The company has recently received positive data from the first
feasibility trial of Prima System in age-related macular degeneration
patients – most of the patients could identify letters and some
sequences of letters.

Read more »

2019-10-09T11:33:32+02:00July 19th, 2019|News|
Go to Top